/ Futurism/ The ByteAdvanced TransportArtificial IntelligenceEarth & EnergyEnhanced HumansFuture SocietyHard ScienceHealth & MedicineOff WorldRobots & MachinesSci-Fi VisionsVirtuality
+Videos+Newsletter+Social
About UsContact UsAdvertise With Us
/ NeoscopeBreakthroughsCancerDevelopmentsDevicesGeneticsMental HealthNeuroscienceOrganic ChemistryRX/MedicinesRobotics/ProstheticsStudiesTreatments
Futurism Logo

Neoscope

Topic

Latest Stories

Illegal Woes
Updated 8.28.19, 1:31 PM EDT on neoscope
Vaping Black-Market Cannabis Oil Is Putting People Into Comas
Weed Need
8.27.19, 2:45 PM EDT on neoscope
DEA Announces Plan to Expand Researchers' Access to Marijuana
Health Boost
8.23.19, 2:19 PM EDT on neoscope
This Cheap "Polypill" Could Reduce Your Risk of a Heart Attack
Death Notice
8.22.19, 2:05 PM EDT on neoscope
This Blood Test Seems to Predict if People Are Going to Die Soon
Lub Dub
8.22.19, 1:05 PM EDT on neoscope
This Steampunk Bionic Heart Uses Maglev Tech to Pump Blood
Theranos, Too
8.22.19, 9:20 AM EDT on neoscope
Microbiome Testing Startup uBiome Based Tests on Infant, Pet Data
Minor Key
8.20.19, 4:12 PM EDT on neoscope
Teen Files Lawsuit Against JUUL, Phillip Morris for Targeting Kids
Showing Teeth
8.20.19, 2:05 PM EDT on neoscope
Scientists Decry New Study Linking Fluoride to Lower IQ in Kids
Futurism
8.20.19, 9:20 AM EDT on neoscope
FDA Proposes Grotesque New Warning Images for Cigarette Packs
Going Dry
Updated 8.19.19, 11:16 AM EDT on neoscope
Study: MDMA Appears to Be an Effective Treatment for Alcoholism
New Cure
8.16.19, 2:37 PM EDT on neoscope
We Have a Cure for the Deadliest Form of Tuberculosis
STIs Down
8.14.19, 9:37 AM EDT on neoscope
New Chlamydia Vaccine Shows Promise In First Human Trial
  • Previous
  • 1
  • ...
  • 211
  • 212
  • 213
  • Next
+Social+Newsletter
TopicsAbout UsEditorial StandardsContact Us

DISCLAIMER(S)

Privacy PolicyTerms & ConditionsDMCA Policy

Articles may contain affiliate links which enable us to share in the revenue of any purchases made.

Registration on or use of this site constitutes acceptance of our Terms of Service.

© Recurrent Ventures Inc, All Rights Reserved.